DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/d032e1/insulin_europe) has announced the addition of the "Insulin- Europe" report to their offering.
The report contains insulin market analyses from 29 European countries. The insulin market analyses give an overview of the actual situation, trends and future outlook of the insulin markets in different European countries. They provide essential market information for decision-makers including:
- Overall market value for insulin, 2004-2010
- Overall market volume for insulin, 2004-2010
- Market value and volume for insulin by type (bulk, dosage)
- Forecasts and future outlook of the market till 2016
- Country overview, macroeconomic indicators and indicators of doing business
The main questions answered by the report titled "Insulin - Europe" are:
- What is the size of the insulin market in different European countries?
- How the insulin market has been developing in different countries? How does the future look like?
- What is the potential for the insulin market in different countries?
- How the indicators of doing business look like? For example, how easily the contracts are being enforced, or what is the inflation rate in and how is it developing?
Countries covered
- Austria
- Belgium
- Bulgaria
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Ireland
- Italy
- Latvia
- Lithuania
- Macedonia
- Moldova
- the Netherlands
- Norway
- Poland
- Portugal
- Romania
- Russia
- Slovakia
- Slovenia
- Spain
- Sweden
- Ukraine
- United Kingdom
For more information visit http://www.researchandmarkets.com/research/d032e1/insulin_europe